Neurodegenerative diseases represent a significant challenge in medical science, impacting millions globally. Despite advancements in diagnostic technology, ...

Nawaloka Hospitals PLC, Sri Lanka’s leading private healthcare provider, has marked another milestone with the introduction of South Asia’s first Artificial Intelligence (AI) driven, Canon Vantage ...

Maisie-Leigh (pictured), of Preston, Lancashire, has just begun gruelling treatment for Ewing sarcoma, starting with nine ...

MOVE Peds will enroll pediatric FSHD patients across eight clinical sites, capturing both early-onset and later-onset pediatric forms of the disease. Using MRI and functional testing optimized for ...

A TEENAGER diagnosed with an aggressive brain tumour and given 12 to 18 months to live spotted the first sign of the deadly disease in her eye. Joscelyne Kerr, 19, was finishing school in 2023 ...

While diagnostic criteria for typical multiple sclerosis (MS) perform well in people ages 18 to 50, differential diagnoses in ...

Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

Tolebrutinib had the most protective effect against disability worsening at 6 months in patients with multiple sclerosis who ...

Proposed McDonald criteria revisions could help diagnose MS patients who would have been missed with earlier versions, an analysis shows.

For the first time, researchers have identified that inflammation—long associated with multiple sclerosis (MS)—appears to ...

Inside Mason Health’s Diagnostic Imaging Department, exciting updates are underway, including replacing the open MRI machine by end of 2025.

1 Queen Square MS Center, NMR Research Unit, Department of Neuroinflammation, UCL Institute of Neurology, London, UK 2 Departments of Neuroinflammation, UCL Institute of Neurology, London, UK 3 Brain ...